Vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 1, 2010, Pages 20-31

  Vidaurreta, M ^a   Sanchez Munoz R ^a   Veganzones, S ^a   Rafael, S ^a   Gutierrez M ^a   de la Orden, V ^a   Fernandez C ^a   Arroyo, M ^a   Cerdan F J ^a   Maestro, M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Colorectal cancer; VEGF polymorphisms

Indexed keywords

VASCULOTROPIN;

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; ASCENDING COLON; COLORECTAL CANCER; DESCENDING COLON; DISEASE FREE SURVIVAL; FEMALE; GENDER; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; OVERALL SURVIVAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR LOCALIZATION;

EID: 77951920346     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010000100004     Document Type: Article

References (24)

1. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular specific growth factors and blood vessel formation. Nature 2000; 407: 242-8.
2. Roy H, Bhardawai S, Yla-Herttuala S. Biology of vascular endothelial growth factors. Febs Lett 2006; 580: 2879-87.
3. Yamamori M, Sakaeda T, Nakamura T, Okamura N, Tamura T, Aoyama N, et al. Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun 2004; 325: 144-50.
4. Lu H, Shu Z-O, Cui Y, Kataoka N, Wen W, Cai Q, et al. Association of genetic polymorphims in the VEGF gene with breast cancer survival. Cancer Res 2005; 65: 5015-19.
5. Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis and survival. J Surg Oncol 2006; 94: 624-30.
6. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6 p21.3.
7. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-5.
8. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology 2003; 62: 374-7.
9. Ku KT, Wan L, Peng HC, Tsai MH, Tsai CH, Tasai FJ. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 2005; 41: 497-502.
10. Renner W, Kotschan S, Hoffman C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial factor plasma levels. J Vasc Res 2000; 37: 443-8.
11. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004; 46: 293-8.
12. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patitients with type 1 diabetes mellitus. J Diabetes Complications 2003; 17: 1-6.
13. Cerdán J. Seguimiento de los pacientes intervenidos de cáncer colorrectal. Rev Cancer 1997; 11: 32-41.
14. Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008; 111(1): 157-63.
15. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
16. Flolkman J. Angiogenesis in cancer, vascular, rheumatoid and ther disease. Nat Med 1995; 1: 27-31.
17. Brogan IJ, Khan N, Isaac K, Hutchison JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 50 UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999; 60: 1245-9.
18. Lemos FB, Mol WM. The beneficial effects of recipient derived vascular endothelial growth factor on graft survival alter kidney transplantation. Transplantation 2005; 79(9): 1221-5.
19. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468-71.
20. Wu G, Hasenberg T, Magdeburg R, Bönninghoff R, Sturm J, Keese M. Association between EGF, TGF-β1, VEGF gene polymorphism and colorectal cancer. World J Surg 2009; 33: 124-9.
21. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, et al. Microvessel density and VEGF expression are prognostic factors in colorrectal cancer. Meta-analysis of the literature. Br J Cancer 2006; 91(12): 1823-32.
22. Chae YS, Kim JG, Sohn SK, Cho YY, Ahn BM, Moon JH, et al. Association of vascular endothelial growth factor gene polymorphisms wit susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 2008; 23: 421-7.
23. Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 2008; 14(1): 62-6.
24. Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis and survival. Molecular Carcinogenesis 2009; 48: 563-9.